Erno Moravcsik

Title: Erno Moravcsik: Innovator in CNS Activity Derivatives

Introduction

Erno Moravcsik is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of chemistry, particularly in the development of compounds with central nervous system (CNS) activity. His work has implications for various therapeutic applications.

Latest Patents

Moravcsik holds a patent for N4-Substituted tetrahydro-1,2,4-oxadiazin-5-one derivatives. This invention relates to new tetrahydro-1,2,4-oxadiazin-5-one derivatives that exhibit CNS activity. Specifically, the patent concerns new N.sup.4-substituted tetrahydro-1,2,4-oxadiazin-5-ones of the formula (1), wherein R.sup.2 is benzyloxycarbonyl or alkylcarbonyl containing 1 to 4 carbon atoms in the alkyl moiety, preferably acetyl. This innovation represents a step forward in the search for effective CNS-active compounds.

Career Highlights

Moravcsik is associated with Richter Gedeon Vegyeszeti Gyar Rt., a prominent pharmaceutical company in Hungary. His work at this institution has allowed him to focus on the synthesis and application of novel chemical compounds. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Throughout his career, Moravcsik has collaborated with esteemed colleagues such as Laszlo Urogdi and Agnes Patthy Nee Lukats. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Erno Moravcsik's contributions to the field of chemistry, particularly through his patent on CNS-active derivatives, highlight his role as an influential inventor. His work continues to impact the pharmaceutical industry and advance scientific knowledge.